Ticagrelor, an oral antiplatelet
indicated for use in acute coronary
syndromes, is a reversibly binding
P2Y12 receptor antagonist and
the subject of this week’s RGH
Pharmacy E-Bulletin.
The Bulletin discusses the
literature around the effects of
ticagrelor-induced dyspnoea.
CLICK HERE to read.The above article was sent to subscribers in Pharmacy Daily's issue from 25 Mar 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Mar 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.